| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5283119
Max Phase: Preclinical
Molecular Formula: C19H12N4O5
Molecular Weight: 376.33
Associated Items:
Representations
Canonical SMILES: O=C(Oc1ccccc1)c1ccccc1Nc1ccc([N+](=O)[O-])c2nonc12
Standard InChI: InChI=1S/C19H12N4O5/c24-19(27-12-6-2-1-3-7-12)13-8-4-5-9-14(13)20-15-10-11-16(23(25)26)18-17(15)21-28-22-18/h1-11,20H
Standard InChI Key: KUAJFCQGVVCOIB-UHFFFAOYSA-N
Associated Targets(Human)
c-Myc/c-Max 51 Activities
HL-60 67320 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Daudi 625 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 376.33 | Molecular Weight (Monoisotopic): 376.0808 | AlogP: 4.09 | #Rotatable Bonds: 5 |
| Polar Surface Area: 120.39 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.15 | CX Basic pKa: | CX LogP: 5.66 | CX LogD: 5.66 |
| Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.24 | Np Likeness Score: -1.35 |
References
| 1. Mancini RS, Barden CJ, Weaver DF, Reed MA.. (2021) Furazans in Medicinal Chemistry., 64 (4.0): [PMID:33569941] [10.1021/acs.jmedchem.0c01901] |
Source
Source(1):